The World Health Organization (WHO) congratulates the Government of Kenya for launching the world’s first malaria vaccine in Homa Bay County, western Kenya.
Indoco Remedies announced that the Inspection Action Group (IAG) of the United Kingdom has confirmed that the GMP status for its Goa Plant I has been fully re-instated by UK regulator, The Medicines and Healthcare Products Regulatory Agency of the United Kingdom (UK-MHRA). This is an outcome of the full GMP inspection conducted by the MHRAfrom May 21 - 23, 2019.
Biocon Ltd announced that it has signed a License and Supply Agreement with a subsidiary of China Medical System Holdings Ltd. (CMS) for three Generic Formulation products in Greater China.
Biocon Ltd announced that it has signed a License and Supply Agreement with a subsidiary of China Medical System Holdings Ltd. (CMS) for three Generic Formulation products in Greater China.
Boehringer Ingelheim and Lupin Limited (Lupin) joined in for a licensing, development and commercialization agreement for Lupin's MEK inhibitor compound (LNP3794) as a potential targeted therapy for patients with difficult-to-treat cancers.
Almost 17 children were affected with hypertrichosis outbreak or werewolf syndrome due to labeling error by pharmaceutical company in Spain. The company named Farm-Química Sur accidentally sold minoxidil which is most commonly used to treat alopecia as omeprazole a drug used to treat heartburn and acid reflux.
EMA has recommended new measures to prevent serious and potentially fatal errors with the dosing of methotrexate for treating inflammatory diseases such as rheumatoid arthritis, psoriasis and Crohn’s disease. The recommendations result from a review of reports that patients are using methotrexate incorrectly despite previous measures to prevent errors.
Global Market Insights, Inc., announces a research report on ‘Vaccines Market Trends and Forecast 2019-2025’. The report covers an extensive summary of the age group, technology, disease, regional, and competitive landscapes. Global Vaccines industry revenue is set to exceed $72.5 billion by 2025.
Global vaccines market size has expanded rapidly owing to increased prevalence of chronic disorders and a rising population base. Improved healthcare systems and better awareness throughout emerging economies has strengthened the demand for critical therapies, while higher disposable incomes and favorable health insurance policies have enabled access to advanced treatment options.
The U.S. Food and Drug Administration approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be administered without an injection.
Pharmaceutical Companies which introduced 22 drugs without prior approval of the National Pharmaceutical Pricing Authority (NPPA) have been issued notices by Government. The NPPA regularly takes action against such companies as per provisions of the Drugs (Prices Control) Order, 2013 (DPCO) which has been issued under the Essential Commodities Act, 1955.
InvaGen Pharmaceuticals, Inc. a wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited announced the receipt of final approval for its Abbreviated New Drug Application (ANDA) for Pregabalin Capsules, 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg and 300mg from the United States Food and Drug Administration (US FDA).
Copyright © 2008-2019, PharmaTutor Edu Labs
Recent Topics